HUM Humana
- 349.550
- -5.700-1.60%
- 350.000
- +0.450+0.13%
Humana News
Humana Inc.'s (NYSE:HUM) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
With its stock down 1.9% over the past month, it is easy to disregard Humana (NYSE:HUM). But if you pay close attention, you might find that its key financial indicators look quite decent, which cou
Barclays Adjusts Price Target on Humana to $370 From $326
Humana (HUM) has an average outperform rating and a price target range of $326 to $473, according to analysts polled by Capital IQ. Price: 355.15, Change: -0.10, Percent Change: -0.03
CMS to Recalculate Ratings for 2024 Medicare Advantage Plans
Express News | CMS - Revised 2025 Bids and Any Formulary Changes Must Be Submitted to CMS No Later Than June 28
Express News | CMS - Medicare Advantage Contracts With Increases in Their Star Ratings Will Have a Time-Limited Opportunity to Resubmit Their 2025 Bids
Express News | CMS - a Contract's Star Rating Will Not Be Decreased by CMS as a Result of the Recalculation
Express News | CMS - Have Assigned All Contracts the Recalculated 2024 Overall and Summary Star Ratings
Express News | CMS - in Light of Recent Court Decisions, Recalculating the 2024 Star Ratings for 2025 Quality Bonus Payment Purposes - Memo Dated June 13
CMS to Recalculate Medicare Advantage Quality Ratings: Report
Express News | Medicare Star Rankings Revision Could Result In Hundreds Of Millions In Additional Bonus Payments For Insurers; Announcement Expected As Soon As Thursday; CMS Plans To Redo Quality Ratings Of Medicare Advantage Plans
Federal Government to Revise Medicare Advantage Plans Ratings
What Happens When Your Insurer Is Also Your Doctor and Your Pharmacist -- Heard on the Street -- WSJ
By David Wainer This is the third in a three-part Heard on the Street series on concentration in American healthcare. Read parts one and two here. America's health insurers don't say this openly, bu
Wolfe Research Adjusts Price Target on Humana to $400 From $373
Humana (HUM) has an average rating of outperform and price targets ranging from $326 to $473, according to analysts polled by Capital IQ.
Cantor Fitzgerald Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $360
Cantor Fitzgerald analyst Sarah James maintains $Humana(HUM.US)$ with a hold rating, and maintains the target price at $360.According to TipRanks data, the analyst has a success rate of 63.0% and a to
Express News | Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $360 Price Target
Humana Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/12/2024 2.67% Cantor Fitzgerald $360 → $360 Reiterates Neutral → Neutral 05/30/2024 6.66% Baird → $374
Cigna Expects Higher Inpatient Medical Activity Throughout 2024
The Cigna Group (NYSE:CI), a leading player in the market for commercial health insurance, said Tuesday that the company expects to witness an increase in inpatient medical activity throughout 2024.
Humana's (HUM) CenterWell Sets Foot in Asheville With New Centers
CenterWell Senior Primary Care Bringing Personalized Care to Asheville Seniors
CenterWell Senior Primary Care is opening two new senior-focused primary care centers in Asheville in 2024. This will mark the company's debut in the area, giving local seniors access to CenterWell's
Bristol Myers Squibb Wins Antitrust Case Against Insurers Regarding Generics
Analysis
Price Target
No Data
